On September 8, 2022 Cardiff Oncology, Inc. ( Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, reported that company management will present and participate in 1×1 investor meetings at the Baird Global Healthcare Conference and the H.C. Wainwright 24th Annual Global Investment Conference taking place in New York, NY, on September 13 – 14, 2022, and September 12 – 14, 2022, respectively (Press release, Cardiff Oncology, SEP 8, 2022, View Source [SID1234619275]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details on the presentations can be found below.

Baird Global Healthcare Conference

H.C. Wainwright 24th Annual Global Investment Conference

A replay of the H.C. Wainwright presentation will be available by visiting the "Events" section of the Cardiff Oncology website after its conclusion.

On September 8, 2022 Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, reported that James Oliviero, President and Chief Executive Officer, will participate in two upcoming investor conferences. Details are as follows (Press release, Fortress Biotech, SEP 8, 2022, View Source [SID1234619274]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 24th Annual Global Investment Conference:

Mr. Oliviero will be presenting a corporate update at the H.C. Wainwright 24th Annual Global Investment Conference. A webcast of the company’s presentation will be available on the News & Events page, located within the Investors section of Checkpoint’s website, View Source, for approximately 30 days after the meeting. Checkpoint will also participate in one-on-one meetings during the conference.

Lake Street’s 6th Annual Best Ideas Growth Conference

On September 8, 2022 Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, reported that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in two upcoming investor conferences in New York City (Press release, Mustang Bio, SEP 8, 2022, View Source [SID1234619273]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the events are as follows:

H.C. Wainwright 24th Annual Global Investment Conference: The company will present a corporate update on Monday, September 12, 2022, at 9:30 a.m. ET and will participate in one-on-one meetings during the conference. A webcast of the company’s presentation will be available on the News & Events page of the Investor Relations section of Mustang’s website, www.mustangbio.com, for approximately 30 days after the meeting.
Cantor Cell & Gene Therapy Conference: The company will participate in a panel presentation on Thursday, September 15, 2022, at 10:40 a.m. ET, titled, "You Can’t Get Anywhere without the CAR-T Keys or GMP Van: Why Manufacturing is Essential." The company will also participate in one-on-one meetings during the conference.

On September 8, 2022 Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, reported that Peter L. Hoang, Marker’s President and Chief Executive Officer, will participate in a panel discussion titled, "CAR-T and Beyond: What Are the Next Generation Cell Therapies?," at the Cantor Fitzgerald Cell and Genetic Medicines Conference in New York on Thursday, September 15, 2022 at 9:20 a.m. ET (Press release, Marker Therapeutics, SEP 8, 2022, View Source [SID1234619271]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Those interested in participating in the conference are encouraged to contact their Cantor Fitzgerald representative.

On September 8, 2022 West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, reported that it will participate in the Bank of America Global Healthcare Conference taking place September 15, 2022, in London, UK, at 1:20 pm British Summer Time (8:20 am EDT) (Press release, West Pharmaceutical Services, SEP 8, 2022, View Source;utm_medium=Email&utm_campaign=Investors_Email&utm_content=8_September_2022&utm_source=West+Pharmaceutical+Services%2C+Inc.&utm_campaign=84d6acacf4-EMAIL_CAMPAIGN_2022_03_31_10_50_COPY_01&utm_medium=email&utm_term=0_4b4b77d239-84d6acacf4-584006100&ct=t(EMAIL_CAMPAIGN_5_12_2022_16_15_COPY_01)#2022-west-to-participate-in-upcoming-investor-conference [SID1234619270]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio webcast will be available in the "Investors" section of the Company’s website at www.westpharma.com. Replay of the webcasts will be available for approximately 90 days after the events.